Published online before print November 10, 2005, doi: 10.1161/01.RES.0000195656.52760.30
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 8, 2005
Revised on October 26, 2005
Accepted on November 2, 2005
PTEN Activity Is Modulated During Ischemia and Reperfusion. Involvement in the Induction and Decay of Preconditioning
Zheqing Cai * and Gregg L. Semenza
From the Vascular Biology Program, Institute for Cell Engineering; the Departments of Pediatrics, Medicine, Oncology, and Radiation Oncology; and the McKusick-Nathans Institute of Genetic Medicine, The Johns Hopkins University School of Medicine, Baltimore, Md.
* To whom correspondence should be addressed. E-mail: czheqin1{at}jhmi.edu.
Ischemic preconditioning (IPC), a brief period of ischemia and reperfusion (I/R), generates profound but transient protection against a subsequent prolonged ischemic episode. The serine-threonine kinase Akt has been shown to mediate IPC, and Akt activation is negatively regulated by the phosphatase PTEN, but whether PTEN activity is modulated by IPC has not been investigated. When isolated, perfused rat hearts were subjected to an IPC stimulus consisting of 15-minute ischemia and 30-minute reperfusion (I-15/R-30), PTEN protein levels and activity were decreased, and levels of phospho-AKT were increased, relative to nonischemic hearts. Hearts subjected to IPC demonstrated improved recovery of cardiac function when subsequently subjected to I-30/R-45 as compared with hearts subjected to I-30/R-45 without prior IPC. When hearts were subjected to I-15 followed by R-30, R-60, or R-120, PTEN reaccumulated gradually and its activity was restored. Phospho-Akt levels at R-120 were decreased and these hearts were no longer protected against injury when subjected to I-30/R-45. Wortmannin administration during reperfusion blocked Akt activation and PTEN reaccumulation. In ischemic hearts, PTEN was rapidly degraded. Pretreatment with proteasome inhibitor MG132 blocked ischemia-induced degradation of PTEN and blocked IPC. Reperfusion following I-15 induced oxidation of the remaining PTEN, leading to Akt activation. Perfusion of H2O2 was sufficient to induce Akt activation. Thus, loss of PTEN activity leads to induction of IPC and feedback mechanisms designed to ensure that Akt activation is transient are responsible for decay of IPC.
Key words: Akt • apoptosis • ischemia • PTEN
This article has been cited by other articles:
 |
|
 |
|
  S. R. Powell and A. Divald The ubiquitin-proteasome system in myocardial ischaemia and preconditioning Cardiovasc Res, October 27, 2009; (2009) cvp321v3. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lee, G. Chanoit, R. McIntosh, D. A. Zvara, and Z. Xu Molecular mechanism underlying Akt activation in zinc-induced cardioprotection Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H569 - H575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Y. Oudit and J. M. Penninger Cardiac regulation by phosphoinositide 3-kinases and PTEN Cardiovasc Res, May 1, 2009; 82(2): 250 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. P. Cai, Z. Shen, L. Van Kaer, and L. C. Becker Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency FASEB J, December 1, 2008; 22(12): 4248 - 4257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Bouhidel, S. Pons, R. Souktani, R. Zini, A. Berdeaux, and B. Ghaleh Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1580 - H1586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Y. Oudit, Z. Kassiri, J. Zhou, Q. C. Liu, P. P. Liu, P. H. Backx, F. Dawood, M. A. Crackower, J. W. Scholey, and J. M. Penninger Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress Cardiovasc Res, June 1, 2008; 78(3): 505 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Murphy and C. Steenbergen Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury Physiol Rev, April 1, 2008; 88(2): 581 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Powell Proteasome Inhibitors in Myocardial Ischemia, Some Concerns Ann. Thorac. Surg., April 1, 2008; 85(4): 1503 - 1504. [Full Text] [PDF]
|
|
|
|
|
|
Z. Cai, H. Zhong, M. Bosch-Marce, K. Fox-Talbot, L. Wang, C. Wei, M. A. Trush, and G. L. Semenza Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1{alpha} Cardiovasc Res, February 1, 2008; 77(3): 463 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kohli, X. Pan, P. Malladi, M. S. Wainwright, and P. F. Whitington Mitochondrial Reactive Oxygen Species Signal Hepatocyte Steatosis by Regulating the Phosphatidylinositol 3-Kinase Cell Survival Pathway J. Biol. Chem., July 20, 2007; 282(29): 21327 - 21336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Cai and G. L. Semenza Is 15-min Ischemia too Lethal to Be an Ischemic Preconditioning Stimulus? Circ. Res., November 10, 2006; 99(10): e86 - e86. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Hausenloy, M. M. Mocanu, and D. M. Yellon Is This Truly Ischemic Preconditioning? Circ. Res., August 18, 2006; 99(4): e11 - e11. [Full Text] [PDF]
|
|